FDA 483 - Scott Health Services LLC - July 22, 2019

An FDA inspection of Scott Health Services, LLC in New Albany, Indiana, revealed a significant deficiency in their clinical trial practices. The firm failed to retain samples of investigational drug product and reference standards used in a bioequivalence study, specifically from a shipment received in July 2018. This lapse prevents the FDA from requesting and analyzing these critical samples as required for regulatory compliance.